Heel pain study pulled before it even started
NCT ID NCT02668510
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study aimed to test whether adding platelet-rich plasma (PRP) to shockwave therapy helps active soldiers with long-lasting plantar fasciitis more than shockwave alone. The trial was withdrawn before enrolling any participants, so no data were collected. The goal was to reduce first-step pain and improve function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- platelet rich plasma (PRP) and extracorporeal shock wave therapy
- What this could lead to
- If it had worked, this could have pointed toward a more effective treatment for stubborn heel pain in active people.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no results are available. It is unclear if PRP adds any benefit over shockwave alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FASCIITIS, PLANTAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
William Beaumont Army Medical Center
El Paso, Texas, 79920, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.